Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clayton P Smith

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Turkish Journal of Urology|May 8, 2018
PI-RADS v2: Current standing and future outlookClayton P Smith, Barış Türkbey
Clinical Lymphoma, Myeloma & Leukemia|August 13, 2022
Cost-Effectiveness of PET Directed Versus Combined Modality Therapy for Early-Stage Favorable Hodgkin's LymphomaClayton P Smith, Bethel Adefres, Eric M Chang, et al.
Abdominal Radiology (New York)|June 22, 2018
Radiomics and radiogenomics of prostate cancerClayton P Smith, Marcin Czarniecki, Sherif Mehralivand, et al.
Current Oncology Reports|March 6, 2019
Novel Imaging in Detection of Metastatic Prostate CancerClayton P Smith, Anna Laucis, Stephanie Harmon, et al.
Journal of Surgical Oncology|November 21, 2023
A systematic review and meta-analysis of pathologic complete response rates for patients with cholangiocarcinoma treated on liver transplant protocolsTrudy C Wu, Clayton P Smith, Joshua S Li, et al.
JTO Clinical and Research Reports|March 16, 2023
Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and OsimertinibClayton P Smith, Michael Xiang, Stephanie M Yoon, et al.
BJR Case Reports|September 14, 2020
Local failure after definitive radiation treatment of lymph-node positive prostate cancer: supporting the use of novel imaging techniques to personalize treatment optionsAvinash R Chaurasia, Clayton P Smith, Peter Pinto, et al.
World Journal of Urology|May 23, 2018
Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?Samuel A Gold, Graham R Hale, Jonathan B Bloom, et al.
Abdominal Radiology (New York)|May 13, 2018
Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?Julie Y An, Stephanie A Harmon, Sherif Mehralivand, et al.
JAMA Network Open|January 3, 2025
PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional ImagingAdrien Holzgreve, Wesley R Armstrong, Kevyn J Clark, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Turkish Journal of Urology|May 8, 2018
PI-RADS v2: Current standing and future outlookClayton P Smith, Barış Türkbey
Clinical Lymphoma, Myeloma & Leukemia|August 13, 2022
Cost-Effectiveness of PET Directed Versus Combined Modality Therapy for Early-Stage Favorable Hodgkin's LymphomaClayton P Smith, Bethel Adefres, Eric M Chang, et al.
Abdominal Radiology (New York)|June 22, 2018
Radiomics and radiogenomics of prostate cancerClayton P Smith, Marcin Czarniecki, Sherif Mehralivand, et al.
Current Oncology Reports|March 6, 2019
Novel Imaging in Detection of Metastatic Prostate CancerClayton P Smith, Anna Laucis, Stephanie Harmon, et al.
Journal of Surgical Oncology|November 21, 2023
A systematic review and meta-analysis of pathologic complete response rates for patients with cholangiocarcinoma treated on liver transplant protocolsTrudy C Wu, Clayton P Smith, Joshua S Li, et al.
JTO Clinical and Research Reports|March 16, 2023
Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and OsimertinibClayton P Smith, Michael Xiang, Stephanie M Yoon, et al.
BJR Case Reports|September 14, 2020
Local failure after definitive radiation treatment of lymph-node positive prostate cancer: supporting the use of novel imaging techniques to personalize treatment optionsAvinash R Chaurasia, Clayton P Smith, Peter Pinto, et al.
World Journal of Urology|May 23, 2018
Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?Samuel A Gold, Graham R Hale, Jonathan B Bloom, et al.
Abdominal Radiology (New York)|May 13, 2018
Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?Julie Y An, Stephanie A Harmon, Sherif Mehralivand, et al.
JAMA Network Open|January 3, 2025
PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional ImagingAdrien Holzgreve, Wesley R Armstrong, Kevyn J Clark, et al.
Pageof 2